drugset / Trial / NCT00092430

Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)

NCT00092430

Phase 3 Completed 1200 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to demonstrate that an investigational refrigerated vaccine with measles, mumps, rubella, and varicella is well tolerated and has similar immune response when compared to a frozen vaccine with measles, mumps, rubella, and varicella.

Timeline

Start
2002-09-26
Primary completion
2003-06-09
Completion
2003-06-09

Drugs

EvaluationDrugModalityDoseRoute
Subject ProQuad Vaccine